Cytori Therapeutics to Present at the 26th Annual Roth Conference on March 12

Cytori Therapeutics, Inc. (NASDAQ:CYTX) will present and provide a corporate update from the 26th Annual Roth Conference on Wednesday, March 12, at 10:30 AM PT.

The presentation will be webcast and may be accessed under “Webcasts” under Cytori’s Investor Relations section of the website. The webcast can be viewed live and will be available for replay after the presentation on the Company's website.

About Cytori

Cytori Therapeutics, Inc. is developing cell therapies based on autologous adipose-derived regenerative cells (ADRCs) to treat cardiovascular disease and other medical conditions. Our scientific data suggest ADRCs improve blood flow, moderate the inflammatory response and keep tissue at risk of dying alive. As a result, we believe these cells can be applied across multiple “ischemic” conditions. These therapies are made available to the physician and patient at the point-of-care by Cytori’s proprietary technologies and products, including the Celution® system product family. www.cytori.com